Insight Pharmaceuticals in Langhorne, Pa., is recalling one lot (34,092 bottles) of Nostrilla Nasal Decongestant nasal spray from the consumer level because it may contain the bacteria Burkholderia cepacia.
The recall was initiated following internal investigations that determined the potential presence of a microbial contaminant that exceeds the product specifications and may consequently result in a subpar product.
Burkholderia cepacia may cause serious infection in individuals with a compromised immune system or chronic lung condition. However, the possibility of infection is small in healthy individuals.
Researchers Find Copper Surfaces Reduce 97% of Bacteria in ICUs
Study: Not Enough Hospital Compliance to Antimicrobial Stewardship Guidelines
The recall was initiated following internal investigations that determined the potential presence of a microbial contaminant that exceeds the product specifications and may consequently result in a subpar product.
Sign up for our FREE E-Weekly for more coverage like this sent to your inbox!
Burkholderia cepacia may cause serious infection in individuals with a compromised immune system or chronic lung condition. However, the possibility of infection is small in healthy individuals.
Related Articles on Infection Control:
Boise State Researchers Create Promising Vaccine for Staph InfectionsResearchers Find Copper Surfaces Reduce 97% of Bacteria in ICUs
Study: Not Enough Hospital Compliance to Antimicrobial Stewardship Guidelines
